arrow
S

Shinji Kawabata

osaka medical and pharmaceutical university
H指数:39
被引数:9,347

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world clinical experience with intravenous perampanel in Japanese patients at perceived high risk for early postoperative or acute symptomatic seizures: A single-center retrospective observational study

日本高风险早期术后或急性症状性癫痫发作患者静脉注射拉莫三嗪的实况临床经验:一项单中心回顾性观察研究

2026-09-010
PRE
Investigator-led clinical trial of boron neutron capture therapy system for recurrent high-grade meningiomas after radiation therapy: Randomized phase II study

硼中子俘获疗法系统治疗放疗后复发性高级别脑膜瘤的发起人主导的临床试验:随机II期研究

2026-04-011
PRE
Perfusion changes associated with intratumoral embolization and feeder occlusion for meningiomas: an arterial spin labeling study

与肿瘤内栓塞和供血动脉闭塞相关的脑膜瘤灌注变化:一项动脉自旋标记研究

2026-02-110
OAAI
Acute symptomatic seizure prevention with perampanel in moderate and severe traumatic brain injury: a retrospective comparison with levetiracetam

中度至重度创伤性脑损伤中急性症状性癫痫发作的预防:与左乙拉西坦的回顾性比较

2025-10-160
OAAI
Ataxin-2 as a candidate blood biomarker for estimating disease status in cases of suspected glioblastoma recurrence

Ataxin-2作为疑似胶质母细胞瘤复发病例中评估疾病状态的候选血液生物标志物

2025-09-220
OA
Phase II trial of pathology-based tripartite treatment stratification for patients with CNS germ cell tumors: A long-term follow-up study
2024-11-020
PRE
Evaluation of sodium borocaptate (BSH) and boronophenylalanine (BPA) as boron delivery agents for neutron capture therapy (NCT) of cancer: an update and a guide for the future clinical evaluation of new boron delivery agents for NCT

硼酸钠(BSH)和硼苯丙氨酸(BPA)作为癌症中子俘获治疗(NCT)硼输送剂的评价:最新进展及未来新型NCT硼输送剂临床评估指南

2024-07-081
OAAI
LONG-TERM OUTCOMES AND COMPLICATION MANAGEMENT IN CNS GERM CELL TUMORS: INSIGHTS FROM A PHASE II HISTOPATHOLOGY-STRATIFIED TREATMENT TRIAL
2024-06-180
OAAI
Evaluation of the Effectiveness of Boron Neutron Capture Therapy with Iodophenyl-Conjugated closo-Dodecaborate on a Rat Brain Tumor Model

碘苯基共轭十二硼酸酯硼中子俘获疗法对大鼠脑肿瘤模型的有效性评估

2023-09-155
OAAI